✦ LIBER ✦

A randomized, placebo-controlled trial of aprotinin to reduce primary graft dysfunction following lung transplantation

✍ Scribed by Cynthia S. Herrington; Matthew E. Prekker; Amanda K. Arrington; Daniel Susanto; Jim W. Baltzell; Leslie L. Studenski; David M. Radosevich; Rosemary F. Kelly; Sara J. Shumway; Marshall I. Hertz; Hartmuth B. Bittner; Peter S. Dahlberg

Book ID: 110890439
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 166 KB
Volume: 25
Category: Article
ISSN: 0902-0063
DOI: 10.1111/j.1399-0012.2010.01319.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

322: A randomized, placebo controlled tr

322: A randomized, placebo controlled trial of aprotinin to reduce primary graft dysfunction following lung transplantation

✍ C.S. Herrington; M.E. Prekker; M.I. Hertz; D.M. Radosevich; R.F. Kelly; V.V. Sul 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 134 KB

405: A Multicenter Prospective, Randomiz

405: A Multicenter Prospective, Randomized, Placebo-Controlled Trial of a CXCL8 Inhibitor (Reparixin) To Prevent Primary Graft Dysfunction after Lung Transplantation

✍ B.F. Meyers; S. Keshavjee; M.R. Zamora; R.D. Davis; M.A. Smith; P.M. McFadden; M 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Long-term follow up of a double-blind, r

Long-term follow up of a double-blind, randomized, placebo-controlled trial of Cyclosporine Inhalation Solution (CyIS) in lung transplant recipients

✍ A.T. Iacono; W.B. Capra; S.B. Shrewsbury; B.A. Johnson; W.F. Grgurich; T.E. Corc 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Low-dose postoperative aprotinin reduces

Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: A prospective, randomized, double-blind, placebo-controlled trial

✍ John M. Alvarez; Lee R. Jackson; Clare Chatwin; Joseph J. Smolich 📂 Article 📅 2001 🏛 CTSNet 🌐 English ⚖ 110 KB

Thymoglobulin Prevents Chronic Graft-ver

Thymoglobulin Prevents Chronic Graft-versus-Host Disease, Chronic Lung Dysfunction, and Late Transplant-Related Mortality: Long-Term Follow-Up of a Randomized Trial in Patients Undergoing Unrelated Donor Transplantation

✍ Andrea Bacigalupo; Teresa Lamparelli; Giovanni Barisione; Paolo Bruzzi; Stefano 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 315 KB

Long-Term follow-up of a Phase I/II Rand

Long-Term follow-up of a Phase I/II Randomized, Placebo-Controlled Trial of Palifermin to Prevent Graft-versus-Host Disease (GVHD) after Related Donor Allogeneic Hematopoietic Cell Transplantation (HCT)

✍ John E. Levine; Bruce R. Blazar; Todd DeFor; James L.M. Ferrara; Daniel J. Weisd 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 160 KB